IRIS Accounts Production v26.2.0.496 07963056 director 1.4.25 31.3.26 31.3.26 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079630562025-03-31079630562026-03-31079630562025-04-012026-03-31079630562024-03-31079630562024-04-012025-03-31079630562025-03-3107963056ns15:EnglandWales2025-04-012026-03-3107963056ns14:PoundSterling2025-04-012026-03-3107963056ns10:Director12025-04-012026-03-3107963056ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3107963056ns10:SmallEntities2025-04-012026-03-3107963056ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3107963056ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3107963056ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3107963056ns10:FullAccounts2025-04-012026-03-3107963056ns10:RegisteredOffice2025-04-012026-03-3107963056ns5:CurrentFinancialInstruments2026-03-3107963056ns5:CurrentFinancialInstruments2025-03-3107963056ns5:ShareCapital2026-03-3107963056ns5:ShareCapital2025-03-3107963056ns5:CapitalRedemptionReserve2026-03-3107963056ns5:CapitalRedemptionReserve2025-03-3107963056ns5:FurtherSpecificReserve1ComponentTotalEquity2026-03-3107963056ns5:FurtherSpecificReserve1ComponentTotalEquity2025-03-3107963056ns5:FurtherSpecificReserve2ComponentTotalEquity2026-03-3107963056ns5:FurtherSpecificReserve2ComponentTotalEquity2025-03-3107963056ns5:RetainedEarningsAccumulatedLosses2026-03-3107963056ns5:RetainedEarningsAccumulatedLosses2025-03-3107963056ns5:PlantMachinery2025-03-3107963056ns5:PlantMachinery2025-04-012026-03-3107963056ns5:PlantMachinery2026-03-3107963056ns5:PlantMachinery2025-03-3107963056ns5:CostValuation2025-03-3107963056ns5:AdditionsToInvestments2026-03-3107963056ns5:DisposalsRepaymentsInvestments2026-03-3107963056ns5:CostValuation2026-03-3107963056ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3107963056ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31
REGISTERED NUMBER: 07963056 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 March 2026

for

KENT SURGEON LTD

KENT SURGEON LTD (REGISTERED NUMBER: 07963056)

Contents of the Financial Statements
for the Year Ended 31 March 2026










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


KENT SURGEON LTD

Company Information
for the Year Ended 31 March 2026







DIRECTOR: G Tsavellas





REGISTERED OFFICE: 2 St Mary's Road
Tonbridge
Kent
TN9 2LB





REGISTERED NUMBER: 07963056 (England and Wales)





ACCOUNTANTS: Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB

KENT SURGEON LTD (REGISTERED NUMBER: 07963056)

Balance Sheet
31 March 2026

2026 2025
Notes £ £
FIXED ASSETS
Tangible assets 4 235 394
Investments 5 - 166
Investment property 6 495,000 495,000
495,235 495,560

CURRENT ASSETS
Debtors 7 5,198 550
Prepayments and accrued income 2,590 2,441
Cash at bank 1,241,824 1,138,883
1,249,612 1,141,874
CREDITORS
Amounts falling due within one year 8 (38,711 ) (41,970 )
NET CURRENT ASSETS 1,210,901 1,099,904
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,706,136

1,595,464

PROVISIONS FOR LIABILITIES (53,424 ) (53,424 )
NET ASSETS 1,652,712 1,542,040

KENT SURGEON LTD (REGISTERED NUMBER: 07963056)

Balance Sheet - continued
31 March 2026

2026 2025
Notes £ £
CAPITAL AND RESERVES
Called up share capital 120 120
Capital redemption reserve 80 80
Other reserves 781,297 781,297
Other reserves 199,185 199,185
Retained earnings 672,030 561,358
1,652,712 1,542,040

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 9 September 2026 and were signed by:





G Tsavellas - Director


KENT SURGEON LTD (REGISTERED NUMBER: 07963056)

Notes to the Financial Statements
for the Year Ended 31 March 2026


1. STATUTORY INFORMATION

Kent Surgeon Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


KENT SURGEON LTD (REGISTERED NUMBER: 07963056)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
COST
At 1 April 2025 4,777
Additions 299
At 31 March 2026 5,076
DEPRECIATION
At 1 April 2025 4,383
Charge for year 458
At 31 March 2026 4,841
NET BOOK VALUE
At 31 March 2026 235
At 31 March 2025 394

KENT SURGEON LTD (REGISTERED NUMBER: 07963056)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026


5. FIXED ASSET INVESTMENTS
Other
investments
£
COST
At 1 April 2025 166
Additions 50,066
Disposals (50,232 )
At 31 March 2026 -
NET BOOK VALUE
At 31 March 2026 -
At 31 March 2025 166

6. INVESTMENT PROPERTY
Total
£
FAIR VALUE
At 1 April 2025
and 31 March 2026 495,000
NET BOOK VALUE
At 31 March 2026 495,000
At 31 March 2025 495,000

The directors have valued the investment property at £495,000 using an online valuation tool.

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£ £
Trade debtors 5,198 550

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£ £
Taxation and social security 35,038 38,682
Other creditors 3,673 3,288
38,711 41,970